Rogaine Extra Strength gains marketing exclusivity until November 2000.
This article was originally published in The Rose Sheet
Executive Summary
P&U ROGAINE EXTRA STRENGTH EXCLUSIVITY AWARD will protect the company's new 5% minoxidil hair regrowth solution from private label competition through Nov. 14, 2000. Pharmacia & Upjohn announced FDA's award of Waxman/Hatch marketing exclusivity Feb. 2. Approval for Rogaine Extra Strength as an over-the-counter drug was granted Nov. 14 ("The Rose Sheet" Nov. 24, 1997, pp. 3-4).